IHC has broadly classified breast cancer into four major molecular subtypes, as described by the St Gallen International Expert Panel, based upon the oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2Neu) status [2, 3]. The gene discussed is PGR; the disease is breast carcinoma.